These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


275 related items for PubMed ID: 8055936

  • 1. Interaction of Serratia marcescens hemolysin (ShlA) with artificial and erythrocyte membranes. Demonstration of the formation of aqueous multistate channels.
    Schönherr R, Hilger M, Broer S, Benz R, Braun V.
    Eur J Biochem; 1994 Jul 15; 223(2):655-63. PubMed ID: 8055936
    [Abstract] [Full Text] [Related]

  • 2. Serratia marcescens hemolysin (ShlA) binds artificial membranes and forms pores in a receptor-independent manner.
    Hertle R.
    J Membr Biol; 2002 Sep 01; 189(1):1-14. PubMed ID: 12202947
    [Abstract] [Full Text] [Related]

  • 3. Serratia type pore forming toxins.
    Hertle R.
    Curr Protein Pept Sci; 2000 Jul 01; 1(1):75-89. PubMed ID: 12369921
    [Abstract] [Full Text] [Related]

  • 4. Pore-forming properties of proteolytically nicked staphylococcal alpha-toxin: the ion channel in planar lipid bilayer membranes.
    Krasilnikov OV, Merzlyak PG, Yuldasheva LN, Azimova RK, Nogueira RA.
    Med Microbiol Immunol; 1997 Jun 01; 186(1):53-61. PubMed ID: 9255767
    [Abstract] [Full Text] [Related]

  • 5. Integration of the Serratia marcescens haemolysin into human erythrocyte membranes.
    Schiebel E, Braun V.
    Mol Microbiol; 1989 Mar 01; 3(3):445-53. PubMed ID: 2664420
    [Abstract] [Full Text] [Related]

  • 6. The haemolysin-secreting ShlB protein of the outer membrane of Serratia marcescens: determination of surface-exposed residues and formation of ion-permeable pores by ShlB mutants in artificial lipid bilayer membranes.
    Könninger UW, Hobbie S, Benz R, Braun V.
    Mol Microbiol; 1999 Jun 01; 32(6):1212-25. PubMed ID: 10383762
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Selective blockage of Serratia marcescens ShlA by nickel inhibits the pore-forming toxin-mediated phenotypes in eukaryotic cells.
    Lazzaro M, Krapf D, García Véscovi E.
    Cell Microbiol; 2019 Sep 01; 21(9):e13045. PubMed ID: 31099073
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxic action of Serratia marcescens hemolysin on human epithelial cells.
    Hertle R, Hilger M, Weingardt-Kocher S, Walev I.
    Infect Immun; 1999 Feb 01; 67(2):817-25. PubMed ID: 9916096
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cluster-forming property correlated with hemolytic activity by staphylococcal γ-hemolysin transmembrane pores.
    Tomita N, Abe K, Kamio Y, Ohta M.
    FEBS Lett; 2011 Nov 04; 585(21):3452-6. PubMed ID: 22001207
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Molecular characterization of the hemolysin determinant of Serratia marcescens.
    Poole K, Schiebel E, Braun V.
    J Bacteriol; 1988 Jul 04; 170(7):3177-88. PubMed ID: 3290200
    [Abstract] [Full Text] [Related]

  • 16. The properties of Bacillus cereus hemolysin II pores depend on environmental conditions.
    Andreeva ZI, Nesterenko VF, Fomkina MG, Ternovsky VI, Suzina NE, Bakulina AY, Solonin AS, Sineva EV.
    Biochim Biophys Acta; 2007 Feb 04; 1768(2):253-63. PubMed ID: 17173854
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Formation of individual protein channels in lipid bilayers suspended in nanopores.
    Studer A, Han X, Winkler FK, Tiefenauer LX.
    Colloids Surf B Biointerfaces; 2009 Oct 15; 73(2):325-31. PubMed ID: 19576736
    [Abstract] [Full Text] [Related]

  • 19. Secretion and activation of the Serratia marcescens hemolysin by structurally defined ShlB mutants.
    Pramanik A, Könninger U, Selvam A, Braun V.
    Int J Med Microbiol; 2014 May 15; 304(3-4):351-9. PubMed ID: 24462008
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.